Evidence map›Paper›PMID 35261922›Full record

ReviewDiscoveries (Craiova, Romania)

Substance use during COVID-19 pandemic: impact on the underserved communities.

Natalia C Chacon, Namrata Walia, Abigail Allen, Anthony Sciancalepore, Joyce Tiong, Rachel Quick, Sanjana Mada, Miguel A Diaz, Ivan Rodriguez

Open access · diamondAbstract readReview
In one paragraph

Review in Discoveries (Craiova, Romania). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Telehealth Use and Health Equity for Mental Health and Substance Use Disorder During the COVID-19 Pandemic: A Systematic Review.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2024
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Natalia C ChaconThe University of Texas Health Science Center School of Public Health, Houston, TX, USA.
Namrata WaliaThe University of Texas Health Science Center School of Public Health, Houston, TX, USA.
Abigail AllenThe University of Texas Health Science Center School of Public Health, Houston, TX, USA.
Anthony SciancaleporeThe University of Texas Health Science Center School of Public Health, Houston, TX, USA.
Joyce TiongThe University of Texas Health Science Center School of Public Health, Houston, TX, USA.
Rachel QuickThe University of Texas Health Science Center School of Public Health, Houston, TX, USA.
Sanjana MadaThe University of Texas Health Science Center School of Public Health, Houston, TX, USA.
Miguel A DiazDepartment of Family Medicine, Larkin Community Hospital, Florida, USA.
Ivan RodriguezDepartment of Family Medicine, Larkin Community Hospital, Florida, USA.
The University of Texas Health Science Center at Houston · USBaylor College of Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The number of overdose deaths are on the rise all over the world. An estimate of 93,000 drug overdose deaths have been estimated in the United States in 2020. COVID-19 pandemic has exacerbated the drug crisis. Factors, such as existing health disparities among underserved communities, lack of resources for people of color, lack of belief in available resources, social isolation and economic burden, limited access to treatment, regulatory barriers in telehealth, and stress from the on-going COVID-19 pandemic have been identified as some of the key factors behind the acute health effects of people with substance use disorder. These interrelated factors exacerbate the impact of already existing disparities in the underserved communities. Policy and regulatory changes around telehealth and access of treatment for substance use disorder are warranted. Evidence-based strategies and other safer drug practices should be implemented to mitigate the impact on human health. Investment in programs that increase access to treatment, will be useful for potential future pandemics, where increasing mental health services and overall access to healthcare in disadvantaged communities would lessen the disparities in physical and mental ailments. In this review, we are evaluating and summarizing the acute health effects of the ongoing COVID-19 pandemic on individuals with substance use disorder.

Indexed as

disparities.pandemicSARS-CoV-2Substance use

Identifiers

PMID35261922
PMCPMC8896880
OpenAlexW4206992616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.